Mental Health News and Research

Latest Mental Health News and Research

Uganda: First vaccination for GMZ2 malaria vaccine trial

Today, the EDCTP-funded GMZ2 consortium starts volunteer enrolment for the phase IIb clinical trial of the candidate malaria vaccine GMZ2 in Uganda. This is the third trial site to initiate volunteer recruitment for this multi-country study. Vaccination is already underway at trial sites in Gabon (November 2010) and Burkina Faso (April 2011). The Uganda site is in the peri-urban area of Iganga/Mayuge, at the Iganga Hospital. Akin to most areas in Uganda, malaria is one of the major health problems in this district. A team from Makerere University (Kampala) is conducting the trial.

9 May 2011

State roundup: Concerns about state employee retirement boom

Plummeting stock portfolios and home values prompted many Baby Boomers to keep working long after retirement age. ... "What was once a planned exit is no longer a planned exit," says Daniel Hackler, Indiana's state personnel director.

9 May 2011

Psychotherapeutic treatment can cure cyclothymic disorder

In the current issue of Psychotherapy and Psychosomatics a group of Italian investigators headed by Giovanni Fava published a randomized controlled trial on psychotherapeutic treatment of cyclothymic disorder, a disturbance that is characterized by rapid alternation of mood swings.

9 May 2011

Elan Drug Technologies, Alkermes merge to form new company in Ireland

Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.

9 May 2011

Mithridion's MCD-386CR receives Orphan Drug designation from FDA for PSP treatment

Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, announces that the U.S. Food and Drug Administration has awarded Orphan Drug designation for MCD-386CR, its lead drug candidate, for the treatment of Progressive Supranuclear Palsy.

9 May 2011

ADHD in children linked to stress and depression during pregnancy

According to the latest research women who are depressed or severely stressed during their pregnancy have a greater chance of having children with attention deficit hyperactivity disorder. It has been known till now that ADHD is largely inheritable but now it comes out that antenatal anxiety could contribute to 15 per cent of cases of the behavioural condition in children.

8 May 2011

Summit Entertainment, Participant Media create depression awareness campaign

Inspired by Participant Media and Summit Entertainment's THE BEAVER, Participant has created a Social public Action Campaign to increase awareness about depression, teaming with three leading non-profit organizations known for effectively providing hope and help to those affected by depression and other forms of mental illness: the National Alliance on Mental Illness, To Write Love on Her Arms (TWLOHA) and the Kristin Brooks Hope Center.

7 May 2011

Research sheds light on transmission of obesity among friends and family

Obesity is socially contagious, according to research published in the past few years. How it is "caught" from others remains a murky area. But findings from Arizona State University researchers published online May 5 in the American Journal of Public Health shed light on the transmission of obesity among friends and family.

7 May 2011

Researchers use virtual computer model to understand schizophrenic brains

Computer networks that can't forget fast enough can show symptoms of a kind of virtual schizophrenia, giving researchers further clues to the inner workings of schizophrenic brains, researchers at The University of Texas at Austin and Yale University have found.

6 May 2011

Novel neurotransmitter could fight against neurological diseases

A team of scientists has discovered that D-aspartic acid is a novel neurotransmitter that could potentially be used in the fight against neurological diseases such as Parkinson's and schizophrenia.

6 May 2011

Omeros' PDE7 program expands addiction franchise

Omeros Corporation today announced that its phosphodiesterase 7 inhibitors demonstrated robust efficacy in animal models of nicotine addiction.

6 May 2011

Pregnant Latinas who endure partner violence more likely to suffer postpartum depression

Latinas who endure violence at the hands of a partner during or within a year of pregnancy are five times more likely to suffer postpartum depression than women who have not experienced such violence, according to a new study by researchers at the UCLA Center for Culture, Trauma and Mental Health Disparities.

6 May 2011

Study examines community-based HIV testing programs in Africa, Southeast Asia

If you want to improve HIV testing rates in remote rural areas, get the community involved, says UCLA's Thomas Coates, who has directed a new study examining HIV testing programs in communities in Africa and Southeast Asia.

6 May 2011

Roundup: Vt. House vote on universal health care could come today; Calif. group warns of rising costs of retiree health care and pensions

The House is slated Thursday to take up a conference committee report on a bill designed to put the state on the path to universal health care by 2017 if not sooner. The bill sets up a new Green Mountain Care Board to design a system to provide health insurance to every Vermont resident.

6 May 2011

COIN hosts nanobiotechnology event on nanomedicines and the regulatory path

The Center of Innovation for Nanobiotechnology (COIN) today announced the upcoming NanoBio Executive Roundtable event to be hosted at RTP Foundation in Durham, NC on May 17, 2011. This Roundtable will tackle regulatory issues surrounding nanomedicine commercialization. The “Nanomedicines and the Regulatory Path” Roundtable will kick off with a presentation from Katherine Tyner, Ph.D., a Chemist in the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA).

5 May 2011

Health officials concerned with mental health problems after QLD floods

According to health experts Ipswich residents need to look out for the mental health of friends and family with the effects of January’s floods still weighing on many people. The Australian Medical Association of Queensland (AMAQ) launched the See the Signs awareness campaign this week to help people spot symptoms of mental health issues like depression.

5 May 2011

CanTeen launches groundbreaking cancer support system

For these young people, a parent’s cancer can cause great disruption to routines and relationships and can contribute to immense feelings of anxiety and isolation. CanTeen offers young people dealing with their parent's cancer a powerful dual support system in the form of an innovative Offspring Support Program (being launched in Melbourne on 11 May and Brisbane on 17 May, with plans to go national) and a practical FREE resource book Now What…? Dealing with your parent’s cancer, which may be the only help they receive during this difficult time.

5 May 2011

Researchers present evidence from first ever general population survey of autism in adulthood

Not a single person identified with autism or asperger's syndrome during a community survey in England actually knew they had the condition, research led by the University of Leicester reveals.

5 May 2011

Insights into psychiatric disorders

Social deficits are common in several psychiatric disorders, including autism spectrum disorders and schizophrenia. Individuals with severe social dysfunction can experience significant difficulties with everyday functioning.

5 May 2011

Headache disorders prevalent but under-treated and cause financial burden, WHO report says

Approximately half to three quarters of adults ages 18 to 65 experienced headache last year, making headache disorders one of the most prevalent but under-treated health problems in the world, according to a report released Tuesday by the WHO, Xinhua reports.

5 May 2011

Mental Health News and Research

Latest Mental Health News and Research

Uganda: First vaccination for GMZ2 malaria vaccine trial

State roundup: Concerns about state employee retirement boom

Psychotherapeutic treatment can cure cyclothymic disorder

Elan Drug Technologies, Alkermes merge to form new company in Ireland

Mithridion's MCD-386CR receives Orphan Drug designation from FDA for PSP treatment

ADHD in children linked to stress and depression during pregnancy

Summit Entertainment, Participant Media create depression awareness campaign

Research sheds light on transmission of obesity among friends and family

Researchers use virtual computer model to understand schizophrenic brains

Novel neurotransmitter could fight against neurological diseases

Omeros' PDE7 program expands addiction franchise

Pregnant Latinas who endure partner violence more likely to suffer postpartum depression

Study examines community-based HIV testing programs in Africa, Southeast Asia

Roundup: Vt. House vote on universal health care could come today; Calif. group warns of rising costs of retiree health care and pensions

COIN hosts nanobiotechnology event on nanomedicines and the regulatory path

Health officials concerned with mental health problems after QLD floods

CanTeen launches groundbreaking cancer support system

Researchers present evidence from first ever general population survey of autism in adulthood

Insights into psychiatric disorders

Headache disorders prevalent but under-treated and cause financial burden, WHO report says

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Mental Health News and Research

Latest Mental Health News and Research

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in